Matches in SemOpenAlex for { <https://semopenalex.org/work/W3170709318> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W3170709318 endingPage "980" @default.
- W3170709318 startingPage "973" @default.
- W3170709318 abstract "Oncological diseases are one of the leading reasons of mortality in the last decade, despite the continued development of modern diagnostics and timely follow-up treatment. Cancer is a disease, characterized by the uncontrolled growth and spread of abnormal cells in the body. Tumor diseases are the second leading cause of death worldwide. In addition to surgical treatment or radiation therapy, chemotherapy is one of the main methods of treatment for patients with cancer. It attacks fast-growing cancer cells using chemicals. Chemotherapy drugs (antimetabolites, alkylating agents, drugs that disrupt DNA synthesis, hormonal drugs, etc.) also attack other healthy cells, which is a major drawback of this method of treatment. Conventional dosage forms have a number of disadvantages - low bioavailability, limited efficacy, poor tissue distribution of the drug substance, side effects. Another major difficulty is the development of drug resistance, which renders therapy ineffective. For these reasons, it is necessary to seek new methods and approaches for the introduction of these medicinal substances. In this review, we present current studies exploring the implementation of controlled drug delivery strategies using nanoparticles in some of the most common oncologic diseases worldwide such as breast cancer, prostate cancer, lung and liver cancer, pancreas and the ovaries cancer. The use of nanoparticles as drug carriers or as diagnostic agents provides new perspectives in the treatment of these cancers. Nanoparticles can improve the water solubility of a number of drugs, resulting in improved bioavailability. The administration of nanoparticles can also use to target antitumor therapy, leading to treatment that is more appropriate on the one hand and reducing adverse reactions on the other. For these reasons, a more in-depth study of the use of nanoparticles in tumor diseases is needed in order to be able to more fully explore their advantages and disadvantages." @default.
- W3170709318 created "2021-06-22" @default.
- W3170709318 creator A5003492811 @default.
- W3170709318 creator A5023762966 @default.
- W3170709318 creator A5047440545 @default.
- W3170709318 creator A5076561485 @default.
- W3170709318 date "2019-10-04" @default.
- W3170709318 modified "2023-09-26" @default.
- W3170709318 title "NEW PERSPECTIVES IN TUMOR TREATMENT THROUGH USING NANOPARTICLES" @default.
- W3170709318 doi "https://doi.org/10.35120/kij3404973a" @default.
- W3170709318 hasPublicationYear "2019" @default.
- W3170709318 type Work @default.
- W3170709318 sameAs 3170709318 @default.
- W3170709318 citedByCount "0" @default.
- W3170709318 crossrefType "journal-article" @default.
- W3170709318 hasAuthorship W3170709318A5003492811 @default.
- W3170709318 hasAuthorship W3170709318A5023762966 @default.
- W3170709318 hasAuthorship W3170709318A5047440545 @default.
- W3170709318 hasAuthorship W3170709318A5076561485 @default.
- W3170709318 hasBestOaLocation W31707093181 @default.
- W3170709318 hasConcept C121608353 @default.
- W3170709318 hasConcept C126322002 @default.
- W3170709318 hasConcept C171250308 @default.
- W3170709318 hasConcept C192562407 @default.
- W3170709318 hasConcept C2776256026 @default.
- W3170709318 hasConcept C2776694085 @default.
- W3170709318 hasConcept C2777292972 @default.
- W3170709318 hasConcept C2779134260 @default.
- W3170709318 hasConcept C2779820397 @default.
- W3170709318 hasConcept C2780035454 @default.
- W3170709318 hasConcept C2780192828 @default.
- W3170709318 hasConcept C509974204 @default.
- W3170709318 hasConcept C530470458 @default.
- W3170709318 hasConcept C71924100 @default.
- W3170709318 hasConcept C98274493 @default.
- W3170709318 hasConceptScore W3170709318C121608353 @default.
- W3170709318 hasConceptScore W3170709318C126322002 @default.
- W3170709318 hasConceptScore W3170709318C171250308 @default.
- W3170709318 hasConceptScore W3170709318C192562407 @default.
- W3170709318 hasConceptScore W3170709318C2776256026 @default.
- W3170709318 hasConceptScore W3170709318C2776694085 @default.
- W3170709318 hasConceptScore W3170709318C2777292972 @default.
- W3170709318 hasConceptScore W3170709318C2779134260 @default.
- W3170709318 hasConceptScore W3170709318C2779820397 @default.
- W3170709318 hasConceptScore W3170709318C2780035454 @default.
- W3170709318 hasConceptScore W3170709318C2780192828 @default.
- W3170709318 hasConceptScore W3170709318C509974204 @default.
- W3170709318 hasConceptScore W3170709318C530470458 @default.
- W3170709318 hasConceptScore W3170709318C71924100 @default.
- W3170709318 hasConceptScore W3170709318C98274493 @default.
- W3170709318 hasIssue "4" @default.
- W3170709318 hasLocation W31707093181 @default.
- W3170709318 hasOpenAccess W3170709318 @default.
- W3170709318 hasPrimaryLocation W31707093181 @default.
- W3170709318 hasRelatedWork W1899936169 @default.
- W3170709318 hasRelatedWork W1990964652 @default.
- W3170709318 hasRelatedWork W2321033326 @default.
- W3170709318 hasRelatedWork W2357406576 @default.
- W3170709318 hasRelatedWork W2378059478 @default.
- W3170709318 hasRelatedWork W2418514417 @default.
- W3170709318 hasRelatedWork W3030082946 @default.
- W3170709318 hasRelatedWork W4207085046 @default.
- W3170709318 hasRelatedWork W4322772323 @default.
- W3170709318 hasRelatedWork W1899415052 @default.
- W3170709318 hasVolume "34" @default.
- W3170709318 isParatext "false" @default.
- W3170709318 isRetracted "false" @default.
- W3170709318 magId "3170709318" @default.
- W3170709318 workType "article" @default.